TLS

4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid

Find entries where: TLS

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
Synonyms	Telmisartan
Identifiers	2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-benzimidazol-1-yl]methyl]phenyl]benzoic acid
Formula	C₃₃ H₃₀ N₄ O₂
Molecular Weight	514.617
Type	NON-POLYMER
Isomeric SMILES	CCCc1nc2c(cc(cc2n1Cc3ccc(cc3)c4ccccc4C(=O)O)c5nc6ccccc6n5C)C
InChI	InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)
InChIKey	RMMXLENWKUUMAY-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	69
Chiral Atom Count	0
Bond Count	74
Aromatic Bond Count	34

Drug Info: DrugBank

DrugBank ID	DB00966
Name	Telmisartan
Groups	approved investigational
Description	Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arterial blood pressure.[A1489,A1490] Recent studies suggest that telmisartan may also have PPAR-gamma agonistic properties that could potentially confer beneficial metabolic effects.[A1492]
Synonyms	4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid 4'-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid Telmisartan 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid Telmisartan sodium 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
Brand Names	Mylan-telmisartan Hctz Micardis 80mg Tab PMS-telmisartan-hctz Telmisartan Hctz Apo-telmisartan Twynsta Ran-telmisartan Ntp-telmisartan Sandoz Telmisartan HCT Telmisartan Actavis TELMISARTAN and HYDROCHLOROTHIAZIDE Teva-telmisartan Hctz Mar-telmisartan Bio-telmisartan Micardis HCT Act Telmisartan/hct Kinzalmono Telmisartan Teva Telmisartan-hctz Auro-telmisartan Hctz Pendo-telmisartan-hctz Pritor Act Telmisartan Apo-telmisartan-amlodipine Pendo-telmisartan Tolura Micardisplus Nra-telmisartan Pharma-telmisartan Ag-telmisartan Telmisartan Telmisartan and Hydrochlorothiazide Teva-telmisartan Van-telmisartan Alembic-telmisartan Ag Telmisartan-hct Alembic-telmisartan/hctz Mint-telmisartan Van-telmisartan-hctz Auro-telmisartan Taro-telmisartan Hctz Tolucombi Micardis Plus Apo-telmisartan/hctz Micardis PMS-telmisartan Telmisartan/hctz Truemed Group LLC Mylan-telmisartan Ntp-telmisartan Hctz Nra-telmisartan Hctz Septa-telmisartan Ach-telmisartan Hctz Telmisartan Teva Pharma Ach-telmisartan Jamp Telmisartan Jamp Telmisartan-hct Kinzalkomb Micardis 40mg Tab Telmisartan and Amlodipine Telmisartan and Hydrochlorthiazide Pritorplus Sandoz Telmisartan Actelsar HCT
Indication	Used alone or in combination with other classes of antihypertensives for the treatment of hypertension.[L44652] Also used in the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes mellitus, as well as the treatment of congestive heart failure (only in patients who cannot tolerate ACE inhibitors).[A255892]
Categories	Agents Acting on the Renin-Angiotensin System Agents causing angioedema Agents causing hyperkalemia Angiotensin 2 Receptor Blocker Angiotensin II receptor antagonists Angiotensin II receptor blockers (ARBs) and calcium channel blockers Angiotensin II receptor blockers (ARBs) and diuretics Angiotensin II receptor blockers (ARBs), plain Angiotensin II Type 1 Receptor Blockers Angiotensin II Type 2 Receptor Blockers Angiotensin Receptor Antagonists Antihypertensive Agents Antihypertensive Agents Indicated for Hypertension BCRP/ABCG2 Inhibitors Benzene Derivatives Benzimidazoles Biphenyl Compounds BSEP/ABCB11 Substrates Cardiovascular Agents Cytochrome P-450 CYP2C19 Inhibitors Cytochrome P-450 CYP2C19 inhibitors (strength unknown) Cytochrome P-450 Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Hypotensive Agents P-glycoprotein inhibitors UGT1A3 substrates
ATC-Code	C09DB04 C09CA07 C09DX08 C09DA07
CAS number	144701-48-4

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Peroxisome proliferator-activated receptor gamma	MGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDL...	unknown	partial agonist
Type-1 angiotensin II receptor	MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVV...	unknown	antagonist
Cytochrome P450 2C19	MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...	unknown	inhibitor
UDP-glucuronosyltransferase 1-3	MATGLQVPLPWLATGLLLLLSVQPWAESGKVLVVPIDGSHWLSMREVLRE...	unknown	substrate
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	inhibitor
Canalicular multispecific organic anion transporter 1	MLEKFCNSTFWNSSFLDSPEADLPLCFEQTVLVWIPLGYLWLLAPWQLLH...	unknown	inhibitor
ATP-binding cassette sub-family G member 2	MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKS...	unknown	inhibitor
Bile salt export pump	MSDSVILRSIKKFGEENDGFESDKSYNNDKKSRLQDEKKGDGVRVGFFQL...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682